GastroP Cancer Research Results

GastroP, GastroProtective: Click to Expand ⟱
Source:
Type:

GastroProtective refers to an effect that helps protect the gastrointestinal mucosa, especially the stomach, from injury caused by acid, NSAIDs, alcohol, infection, oxidative stress, or inflammation. Gastroprotective actions may involve enhancement of mucus and bicarbonate defenses, preservation of mucosal blood flow, reduction of oxidative damage, suppression of inflammatory signaling, and support of epithelial repair. In cancer and IBD-related contexts, gastroprotective or broader mucosal-protective effects may be relevant when a compound reduces treatment-related GI injury, limits inflammatory mucosal damage, or helps preserve barrier integrity, although this term is supportive and protective rather than a direct anticancer mechanism.
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
Scientific Papers found: Click to Expand⟱
6023- CGA,    Pharmacological advances of the chlorogenic acids family: current insights and future research directions
- Review, AD, NA - Review, Park, NA - Review, IBD, NA
*Aβ↓, *neuroP↑, *cardioP↑, *GastroP↑, *RenoP↑, *hepatoP↑, *Obesity↓, *Bacteria↓, *BioAv↑, *BioAv↑, *BioAv↑, *ROS↓, *GutMicro↑, *IBI↑, *MCT1↓, *NF-kB↓, *DNMT1↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

ROS↓, 1,  

Cell Death ⓘ

MCT1↓, 1,  

DNA Damage & Repair ⓘ

DNMT1↓, 1,  

Barriers & Transport ⓘ

GastroP↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling ⓘ

NF-kB↓, 1,  

Protein Aggregation ⓘ

Aβ↓, 1,  

Drug Metabolism & Resistance ⓘ

BioAv↑, 3,  

Clinical Biomarkers ⓘ

GutMicro↑, 1,  

Functional Outcomes ⓘ

cardioP↑, 1,   hepatoP↑, 1,   neuroP↑, 1,   Obesity↓, 1,   RenoP↑, 1,  

Infection & Microbiome ⓘ

Bacteria↓, 1,  
Total Targets: 15

Scientific Paper Hit Count for: GastroP, GastroProtective
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:75  Cells:%  prod#:%  Target#:1459  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page